Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
With zero based budgeting, you allocate funds toward emergencies first, building a reliable cushion and reducing financial stress when surprises arise.
17,790 articlesVertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Visa reports solid growth as it guards a $700 billion payments empire against threats from real-time rails and crypto...
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Over the last year, small-cap index funds have posted surprisingly strong returns. This article explains why that hap...
Crypto signals aren’t just about price. A single XRP on-chain metric recently jumped 920% in 30 days, triggering ques...
You don’t have to run every deal to build real estate wealth. This guide shows how to fire yourself still scale—deleg...
Active fund moves can shake even steady income plays. This article breaks down why cushing asset management sells Hes...
When a small-cap tech company reports results that miss expectations, the stock often takes a hit. This piece dives i...
Rate launches RateFi to allow crypto holders to qualify for mortgages using digital assets as income and reserves, wi...
As Xometry heads into 2025 earnings, investors seek clarity on growth, margins, and execution. This guide provides ac...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...